CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in participants with human epidermal growth factor 2 (HER2)-expressing (immunohistochemistry \[IHC\] 3+/2+/1+) advanced high-grade epithelial ovarian...
Phase 3
Taipei, Taiwan and 207 other locations
Ovarian cancer (OC) is a lethal disease. The purpose of this study is to assess the safety, pharmacokinetics and efficacy of ABBV90 ...
Phase 1
Taipei, Taiwan and 21 other locations
choice of chemotherapy in subjects with platinum-resistant ovarian cancer whose tumors are positive for cyclin E1 protein expressio...
Phase 3
Taipei, Taiwan and 58 other locations
(PFS) in women with high-grade, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, expressing hig...
Phase 3
Taipei, Taiwan and 298 other locations
with or without bevacizumab compared to standard of care (SoC) as maintenance treatment in participants with platinum-sensitive relapsed ovarian...
Phase 3
Taipei, Taiwan and 78 other locations
"study drug". The study is focused on participants who have advanced ovarian cancer.The aim of the study is to see how safe, tolera...
Phase 2
Taipei, Taiwan and 55 other locations
Researchers are looking for new ways to treat ovarian cancer (OC). Current treatment for OC may start with surgery to remove as muc...
Phase 3
Taipei, Taiwan and 162 other locations
cycles of a standard six-cycle chemotherapy regimen (paclitaxel and carboplatin), for the treatment of subjects with newly diagnosed advanced ovarian...
Phase 3
Taipei, Taiwan and 149 other locations
This study will evaluate the safety and efficacy of R-DXd therapy in participants with ovarian, peritoneal, or fallopian tube cancer...
Phase 2, Phase 3
Taipei, Taiwan and 163 other locations
following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...
Phase 3
Taipei, Taiwan and 237 other locations
Clinical trials
Research sites
Resources
Legal